Biosketch / Results /

Su Wang

Clinical Instructor, Department of Medicine

Contact Info

Su.Wang@nyumc.org


A comprehensive screening and treatment model for reducing disparities in hepatitis B
Pollack, Henry; Wang, Su; Wyatt, Laura; Peng, Chia-Hui; Wan, Kejia; Trinh-Shevrin, Chau; Chun, Kay; Tsang, Thomas; Kwon, Simona. A comprehensive screening and treatment model for reducing disparities in hepatitis B. Health affairs. 2011 Oct ;30(10):1974-1983 (140022)

The asian american hepatitis B program: building a coalition to address hepatitis B health disparities
Trinh-Shevrin, Chau; Pollack, Henry J; Tsang, Thomas; Park, Jihyun; Ramos, Mary Ruchel; Islam, Nadia; Wang, Su; Chun, Kay; Sim, Shao-Chee; Pong, Perry; Rey, Mariano Jose; Kwon, Simona C. The asian american hepatitis B program: building a coalition to address hepatitis B health disparities. Progress in community health partnerships : research, education, & action. 2011 Oct ;5(3):261-271 (143334)

Hepatitis B virus in the United States
Wang, Su H; Pong, Perry; Pollack, Henry. Hepatitis B virus in the United States [Letter]. Annals of internal medicine. 2011 Aug 2;155(3):204-5; author reply 205 (143335)

Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells
Zhong, Zhaojing; Carroll, Kyla Driscoll; Policarpio, Desiree; Osborn, Carla; Gregory, Michael; Bassi, Rajiv; Jimenez, Xenia; Prewett, Marie; Liebisch, Gregory; Persaud, Kris; Burtrum, Douglas; Wang, Su; Surguladze, David; Ng, Stanley; Griffith, Heather; Balderes, Paul; Doody, Jacqueline; Schwartz, Jonathan D; Youssoufian, Hagop; Rowinsky, Eric K; Ludwig, Dale L; Witte, Larry; Zhu, Zhenping; Wu, Yan. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells. Clinical cancer research. 2010 Feb 9;16(4):1191-1205 (144143)

Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia
Colovai, Adriana I; Tsao, Lawrence; Wang, Su; Lin, Hana; Wang, Chuan; Seki, Tetsunori; Fisher, Julie G; Menes, Manuel; Bhagat, Govind; Alobeid, Bachir; Suciu-Foca, Nicole. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia. Cytometry. Part B, Clinical cytometry. 2007 Sep ;72(5):354-362 (94660)